EUVIMEDEUVIMED entdecken
Crossref

A custom next-generation sequencing panel for 1p/19q codeletion and mutational analysis in gliomas

Peng Qi iD, Qian-Lan Yao, I Weng Lao, Min Ren, Qian-Ming Bai, Xu Cai, Tian Xue, Ran Wei, Xiao-Yan Zhou

Journal of Neuropathology & Experimental Neurology · 2024

DOI: 10.1093/jnen/nlae011 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neuropathology & Experimental Neurology, 2024. Verfasst von Peng Qi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, China. Hauptthemen laut MEDLINE: Brain Neoplasms, Glioma. Die Arbeit nennt 55 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Innovation Group Project of Shanghai Municipal Health Commission, Shanghai Science and Technology Development Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The World Health Organization has updated their classification system for the diagnosis of gliomas, combining histological features with molecular data including isocitrate dehydrogenase 1 and codeletion of chromosomal arms 1p and 19q. 1p/19q codeletion analysis is commonly performed by fluorescence in situ hybridization (FISH). In this study, we developed a 57-gene targeted next-generation sequencing (NGS) panel including 1p/19q codeletion detection mainly to assess diagnosis and potential treatment response in melanoma, gastrointestinal stromal tumor, and glioma patients. Loss of heterozygosity analysis was performed using the NGS method on 37 formalin-fixed paraffin-embedded glioma tissues that showed 1p and/or 19q loss determined by FISH. Conventional methods were applied for the validation of some glioma-related gene mutations. In 81.1% (30 of 37) and 94.6% (35 of 37) of cases, 1p and 19q were found to be in agreement whereas concordance for 1p/19q codeletion and no 1p/19q codeletion was found in 94.7% (18 of 19) and 94.4% (17 of 18) of cases, respectively. Overall, comparing NGS results with those of conventional methods showed high concordance. In conclusion, the NGS panel allows reliable analysis of 1p/19q codeletion and mutation at the same time.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brain NeoplasmsGliomaHumansIn Situ Hybridization, FluorescenceChromosome AberrationsMutationHigh-Throughput Nucleotide SequencingIsocitrate DehydrogenaseChromosomes, Human, Pair 1Chromosomes, Human, Pair 19

Stichwörter der Autor:innen

1p/19qFluorescence in situ hybridizationGliomaLoss of heterozygosityMolecular pathologyNext-generation sequencing

Substanzen

Isocitrate Dehydrogenase

Autor:innen und Institutionen

  • Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Institute of Pathology, Fudan University, Shanghai, China.

ORCID-Profile: Peng Qi

Förderung

  • National Natural Science Foundation of China
  • Innovation Group Project of Shanghai Municipal Health Commission
  • Shanghai Science and Technology Development Foundation
  • Shanghai Municipal Key Clinical Specialty
  • Innovation Program of Shanghai Science and Technology Committee
  • Clinical Research Plan of Shanghai Hospital Development Center

Zitieren

APA

Qi, P., Yao, Q. L., Lao, I. W., Ren, M., Bai, Q. M., Cai, X., Xue, T., Wei, R., & Zhou, X. Y. (2024). A custom next-generation sequencing panel for 1p/19q codeletion and mutational analysis in gliomas. Journal of Neuropathology & Experimental Neurology. https://doi.org/10.1093/jnen/nlae011

Vancouver

Qi P, Yao QL, Lao IW, Ren M, Bai QM, Cai X, et al. A custom next-generation sequencing panel for 1p/19q codeletion and mutational analysis in gliomas. Journal of Neuropathology & Experimental Neurology. 2024. doi:10.1093/jnen/nlae011

BibTeX
@article{Qi2024,
  author = {Qi, Peng and Yao, Qian-Lan and Lao, I Weng and Ren, Min and Bai, Qian-Ming and Cai, Xu and Xue, Tian and Wei, Ran and Zhou, Xiao-Yan},
  title = {A custom next-generation sequencing panel for 1p/19q codeletion and mutational analysis in gliomas},
  journal = {Journal of Neuropathology & Experimental Neurology},
  year = {2024},
  doi = {10.1093/jnen/nlae011}
}
Kostenlos starten →